Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis
Public ClinicalTrials.gov record NCT03920293. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients With Generalized Myasthenia Gravis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to evaluate the safety and efficacy of ravulizumab for the treatment of participants with generalized myasthenia gravis (gMG).
Study identification
- NCT ID
- NCT03920293
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 175 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 12, 2019 (Actual)
- Primary completion
- May 11, 2021 (Actual)
- Completion
- May 25, 2023 (Actual)
- Last update posted
- May 28, 2024
2019 – 2023
United States locations
- U.S. sites
- 49
- U.S. states
- 24
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85013 | — |
| Research Site | Phoenix | Arizona | 85018 | — |
| Research Site | Phoenix | Arizona | 85028 | — |
| Research Site | Irvine | California | 92617 | — |
| Research Site | Loma Linda | California | 92354 | — |
| Research Site | Palo Alto | California | 94304 | — |
| Research Site | San Francisco | California | 94115 | — |
| Research Site | Sylmar | California | 91342 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Colorado Springs | Colorado | 80907 | — |
| Research Site | Fort Collins | Colorado | 80528 | — |
| Research Site | Fairfield | Connecticut | 06824 | — |
| Research Site | Washington D.C. | District of Columbia | 20007 | — |
| Research Site | Jacksonville | Florida | 32209 | — |
| Research Site | Tampa | Florida | 33612 | — |
| Research Site | Chicago | Illinois | 60637 | — |
| Research Site | Rolling Meadows | Illinois | 60008 | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | Kansas City | Kansas | 66160 | — |
| Research Site | Lexington | Kentucky | 40503 | — |
| Research Site | Baltimore | Maryland | 21287 | — |
| Research Site | Boston | Massachusetts | 02116 | — |
| Research Site | Burlington | Massachusetts | 01805 | — |
| Research Site | Ann Arbor | Michigan | 48109 | — |
| Research Site | East Lansing | Michigan | 48824 | — |
| Research Site | Grand Rapids | Michigan | 49525 | — |
| Research Site | Columbia | Missouri | 65201 | — |
| Research Site | Las Vegas | Nevada | 89104 | — |
| Research Site | Las Vegas | Nevada | 89145 | — |
| Research Site | Great Neck | New York | 11021 | — |
| Research Site | New York | New York | 10021 | — |
| Research Site | Chapel Hill | North Carolina | 27599 | — |
| Research Site | Charlotte | North Carolina | 28207 | — |
| Research Site | Durham | North Carolina | 27710 | — |
| Research Site | Cincinnati | Ohio | 45219 | — |
| Research Site | Cleveland | Ohio | 44195 | — |
| Research Site | Columbus | Ohio | 43221 | — |
| Research Site | Hershey | Pennsylvania | 17033 | — |
| Research Site | Philadelphia | Pennsylvania | 19104 | — |
| Research Site | Pittsburgh | Pennsylvania | 15212 | — |
| Research Site | Charleston | South Carolina | 29425 | — |
| Research Site | North Charleston | South Carolina | 29406 | — |
| Research Site | Austin | Texas | 78756 | — |
| Research Site | Dallas | Texas | 75206 | — |
| Research Site | Houston | Texas | 77030 | — |
| Research Site | Round Rock | Texas | 78681 | — |
| Research Site | Burlington | Vermont | 05401 | — |
| Research Site | Richmond | Virginia | 23298 | — |
| Research Site | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03920293, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 28, 2024 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03920293 live on ClinicalTrials.gov.